SkyCell developed the next generation of temperature controlled logistics containers for the pharmaceutical industry.
SkyCell has raised €249M across 6 funding rounds from 7 investors, most recently a Series D+ round in Jun 2024. Based in Zurich, Switzerland; founded 2012; active in Transportation. Data as of 6 Aug 2026.
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2024-06-25 | Series D+ | €108M | — | View deal → |
| 2023-10-31 | Other | €54M | M&G's Catalyst Fund | View deal → |
| 2023-05-24 | Other | — | Lazard Asset Management | View deal → |
| 2021-10-11 | Series C | €30M | DisruptAD,Private Investors,SHUAA Capital | View deal → |
| 2020-04-28 | Other | €57M | MVM Life Science Partners | View deal → |
| 2019-10-01 | Other | €0 | Capital Transmission | View deal → |
